|Last Price$90.44||Day Change (%)0.27%|
|Open Price$90.07||Day Change ($)0.24|
|Day Range90.01–91.21||52-Week Range65.08–91.21|
As of Fri 5/22/2015 5:00:00 PM | USD
The fact that the Fed minutes were a non-event this week is a good sign for its communication policy. Plus, Wal-Mart shares a good buy for the patient, and more.
For CVS, Big Bet On Pricey Medicines
Express Scripts Research Highlights $52 Billion Challenge for U.S. Healthcare System
SaveRxAccess Raises Concerns on Department of Defense Cuts for Essential Medications for Thousands of Military Members
Express Scripts Announces Accelerated Share Repurchase Transaction
Investors can pick up shares of this pharmacy benefit manager, which enjoys enormous supplier-pricing and scale advantages, at a significant discount.
Vertex's Cystic-Fibrosis Drug Faces Big Test
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
The wide-moat pharmacy benefit manager is still undervalued.
Pharmacy benefit managers aren't household names, but recent consolidation in the industry is proving out the power of scale for these firms, says Morningstar's Matt Coffina.